Table 1.
Baseline characteristics of the respondents [n (%)]
| ALL | Very high HDI—North Americaa | Very high HDI—Europeb | Very high HDI—Otherc | High HDId | Medium HDIe | Low HDIf | No country information | |
|---|---|---|---|---|---|---|---|---|
| n = 204 | n = 69 | n = 43 | n = 15 | n = 20 | n = 21 | n = 3 | n = 33 | |
| Job | ||||||||
| Academic | 163 (79.9) | 64 (92.8) | 41 (95.3) | 15 (100) | 20 (100) | 20 (95.2) | 3 (100) | 0 (0) |
| Nonacademic | 8 (3.9) | 5 (7.2) | 2 (4.7) | 0 (0) | 0 (0) | 1 (4.8) | 0 (0) | 0 (0) |
| Missing | 33 (16.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 33 (100) |
| Position | ||||||||
| Faculty | 139 (68.1) | 55 (79.7) | 32 (74.4) | 11 (73.3) | 18 (90) | 20 (95.2) | 3 (100) | 0 (0) |
| Student | 19 (9.3) | 9 (13) | 4 (9.3) | 4 (26.7) | 2 (10) | 0 (0) | 0 (0) | 0 (0) |
| Other g | 13 (6.4) | 5 (7.3) | 7 (16.3) | 0 (0) | 0 (0) | 1 (4.8) | 0 (0) | 0 (0) |
| Missing | 33 (16.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 33 (100) |
| Highest professional title | ||||||||
| PhD | 106 (52) | 36 (52.2) | 24 (55.8) | 10 (66.7) | 14 (70) | 12 (57.1) | 1 (33.3) | 9 (27.2) |
| MD | 23 (11.3) | 10 (14.5) | 4 (9.3) | 1 (6.7) | 1 (5) | 4 (19) | 0 (0) | 3 (9.1) |
| MD/PhD | 23 (11.3) | 4 (5.8) | 11 (25.6) | 2 (13.3) | 3 (15) | 1 (4.8) | 0 (0) | 2 (6.1) |
| PharmD | 20 (9.8) | 11 (15.9) | 2 (4.7) | 0 (0) | 0 (0) | 1 (4.8) | 0 (0) | 6 (18.2) |
| PharmD/PhD | 9 (4.4) | 2 (2.9) | 0 (0) | 1 (6.7) | 2 (10) | 0 (0) | 0 (0) | 4 (12.1) |
| Master's | 14 (6.9) | 4 (5.8) | 1 (2.3) | 1 (6.7) | 0 (0) | 3 (14.3) | 2 (66.7) | 3 (9.1) |
| Other h | 3 (1.5) | 1 (1.4) | 1 (2.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (3) |
| Missing | 6 (2.9) | 1 (1.4) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (15.2) |
| Attendance or provision of educational talks on pharmacogenetics over the past year | ||||||||
| None | 18 (8.8) | 6 (8.7) | 3 (7) | 1 (6.7) | 1 (5) | 4 (19) | 1 (33.3) | 2 (6.1) |
| One | 26 (12.7) | 9 (13) | 3 (7) | 0 (0) | 7 (35) | 3 (14.3) | 0 (0) | 4 (12.2) |
| Two | 34 (16.7) | 8 (11.6) | 6 (14) | 3 (20) | 5 (25) | 7 (33.3) | 0 (0) | 5 (15.2) |
| More than two | 117 (57.4) | 44 (63.8) | 31 (72.1) | 11 (73.3) | 7 (35) | 6 (28.6) | 1 (33.3) | 17 (51.5) |
| Missing | 9 (4.4) | 2 (2.9) | 0 (0) | 0 (0) | 0 (0) | 1 (4.8) | 1 (33.3) | 5 (15.2) |
HDI: Human Development Index (2018).
USA (62), Canada (7).
Belarus (1), Bulgaria (1), Croatia (1), Denmark (1), Estonia (1), France (1), Germany (4), Iceland (1), Italy (9), New Zealand (1), Portugal (1), Slovenia (3), Spain (4), Sweden (2), Switzerland (2), The Netherlands (8), UK (2).
Argentina (1), Australia (2), Brunei (1), Malaysia (8), Saudi Arabia (1), Singapore (1), United Arab Emirates (1).
Brazil (6), Iran (2), Jordan (5), Kosovo (1), Lebanon (2), Mexico (2), Republic of Moldova (1), Turkey (1).
Bangladesh (2), India (13), Indonesia (3), Pakistan (1), Palestine (1), South Africa (1).
Eritrea (1), Nigeria (1), Sudan (1).
Chief Technology Officer (1), Chief Technology Officer and Chief Security Officer (1), Clinical Development Pharmacist (1), Manager (1), Researcher (3), Senior Research Fellow (1), Staff (3), Teaching Assistant (1), Visiting Scientist (1).
BSc (Bachelor of Sciences) (1), MD Candidate (1), Registered Pharmacist (1).